Visi / NASDAQ / IRulya Therapeutics

IRulya Therapeutics

IRulya Therapeutics

Investuok be komisinių

Pirk ir parduok dalines akcijas vos už 1 €

Informacija ir statistika

Dienos intervalas
1 D.−100,00 %
3 MĖN.−100,00 %
1 SAV.−100,00 %
6 MĖN.−100,00 %
1 MĖN.−100,00 %
1 M.−100,00 %
SIMBOLIS
IRLA
RINKA
NASDAQ
ISIN
US22053A3059

Data

Uždara

Pokytis

Pokytis (%)

Atvira

Didelė

Maža

33,083,3310,07 %29,7533,0827,39
32,83−2,87−8,74 %35,7035,7031,34
34,68−5,31−15,31 %39,9940,9834,01
40,275,2913,14 %34,9840,6234,79
34,453,449,99 %31,0134,5031,01
32,03−0,17−0,53 %32,2034,3231,62
33,234,2412,76 %28,9933,7128,99
30,003,2810,93 %26,7230,0026,72
27,87−0,64−2,3 %28,5130,3525,50
32,404,2313,06 %28,1732,6026,92
31,731,233,88 %30,5037,0030,20
29,362,277,73 %27,0929,8026,84
26,72−0,02−0,07 %26,7427,9526,72
26,81−0,87−3,25 %27,6828,1526,81
28,10−0,89−3,17 %28,9929,7628,01
29,20−1,00−3,42 %30,2030,7029,20
30,68−1,31−4,27 %31,9931,9929,20
31,01−0,96−3,1 %31,9732,5930,62
31,171,374,4 %29,8032,0029,63
29,00−1,00−3,45 %30,0030,9526,90
31,000,601,94 %30,4031,0029,98
30,00−0,81−2,7 %30,8130,8129,65
30,15−0,86−2,85 %31,0131,0129,47
31,35−1,44−4,59 %32,7932,7930,50
31,001,825,87 %29,1831,0029,10
29,482,277,7 %27,2129,8927,21
27,01−0,16−0,59 %27,1727,5626,62
27,17−0,22−0,81 %27,3928,4025,77
28,840,270,94 %28,5729,9027,15
28,59−0,69−2,41 %29,2829,2826,99
29,550,672,27 %28,8830,0028,88
28,96−1,04−3,59 %30,0030,0028,31
30,310,842,77 %29,4730,3129,01
29,50−2,38−8,07 %31,8831,8829,01
31,320,792,52 %30,5333,4030,00
30,55−2,41−7,89 %32,9632,9630,55
32,15−0,77−2,4 %32,9233,0532,04
32,11−0,92−2,87 %33,0333,4832,11
32,57−1,47−4,51 %34,0434,0432,17
33,750,842,49 %32,9135,3431,84
32,500,511,57 %31,9932,7329,95
31,31−0,59−1,88 %31,9032,0131,31
30,93−1,47−4,75 %32,4033,6930,93
32,50−0,50−1,54 %33,0033,5032,50
33,930,782,3 %33,1534,0832,57
32,11−2,46−7,66 %34,5734,9532,11
34,571,684,86 %32,8934,9031,25
32,91−0,09−0,27 %33,0034,8432,66
34,12−0,83−2,43 %34,9535,2333,08
34,042,266,64 %31,7835,0431,78
32,411,073,3 %31,3433,7330,95
31,26−1,66−5,31 %32,9232,9230,03
32,731,233,76 %31,5033,0930,50
30,650,652,12 %30,0031,4730,00
30,200,280,93 %29,9230,6529,37
29,540,371,25 %29,1730,3228,55
28,881,725,96 %27,1629,9927,16
27,411,766,42 %25,6527,4824,80
24,961,024,09 %23,9426,6123,50
23,39−0,08−0,34 %23,4724,5921,90
23,031,225,3 %21,8123,6521,76
22,002,4911,32 %19,5122,4018,42
19,371,909,81 %17,4719,3717,44
17,850,201,12 %17,6518,2817,64
17,85−0,43−2,41 %18,2818,2817,51
18,280,040,22 %18,2418,6317,82
18,54−0,10−0,54 %18,6418,8817,55
18,78−0,21−1,12 %18,9919,1318,54
18,82−0,06−0,32 %18,8819,3818,29
18,880,201,06 %18,6818,8817,98
18,67−0,15−0,8 %18,8220,6518,47
18,58−0,51−2,74 %19,0919,6317,32
19,292,5913,43 %16,7019,9816,24
17,25−0,54−3,13 %17,7918,2017,21
17,540,100,57 %17,4417,7017,23
17,490,010,06 %17,4817,7216,92
17,25−0,49−2,84 %17,7417,7416,90
17,500,623,54 %16,8817,8416,39
16,98−0,23−1,35 %17,2117,3516,82
17,230,925,34 %16,3117,2416,07
16,75−1,25−7,46 %18,0018,0015,10
18,19−0,33−1,81 %18,5219,2416,84
18,41−0,19−1,03 %18,6019,4017,68
18,87−0,07−0,37 %18,9420,2018,56
19,520,492,51 %19,0319,7018,64
19,03−1,17−6,15 %20,2020,2018,95
19,360,964,96 %18,4020,0018,00
18,550,150,81 %18,4018,9318,23
18,900,904,76 %18,0019,9617,85
18,060,100,55 %17,9618,8517,69
18,01−0,39−2,17 %18,4018,4618,00
18,620,010,05 %18,6119,6018,40
18,67−0,13−0,7 %18,8019,9118,33
18,940,542,85 %18,4019,2217,80
18,20−1,40−7,69 %19,6020,3018,20
19,40−0,40−2,06 %19,8020,2019,10
20,00−0,40−2 %20,4020,6020,00
20,20−1,40−6,93 %21,6021,7020,20
22,001,607,27 %20,4023,0020,20
20,60−0,80−3,88 %21,4021,4020,00
21,00−1,00−4,76 %22,0022,2021,00
22,20−0,80−3,6 %23,0023,6022,20
23,00−0,60−2,61 %23,6024,4023,00
23,400,401,71 %23,0023,8022,20
23,00−1,00−4,35 %24,0025,2023,00
24,002,6010,83 %21,4025,6021,20
22,001,205,45 %20,8022,6020,80
21,40−0,40−1,87 %21,8021,8020,20
21,600,200,93 %21,4022,0020,20
21,400,602,8 %20,8022,2019,20
19,90−6,90−34,67 %26,8027,0018,00
23,00−0,60−2,61 %23,6023,6022,80
23,60−0,40−1,69 %24,0024,4023,60
24,400,000 %24,4025,4024,00
25,200,803,17 %24,4025,2024,00
24,80−0,40−1,61 %25,2025,2024,40
25,600,000 %25,6026,4024,00
26,001,405,38 %24,6026,2024,20
24,40−0,40−1,64 %24,8025,8024,40
24,60−0,20−0,81 %24,8025,0023,60
24,40−1,00−4,1 %25,4025,8024,20
26,601,003,76 %25,6026,8025,20
26,202,208,4 %24,0026,4024,00
24,60−0,20−0,81 %24,8025,2024,00
24,60−0,40−1,63 %25,0025,4023,40
25,80−0,60−2,33 %26,4026,8025,00
27,20−0,20−0,74 %27,4027,4026,20
27,20−0,20−0,74 %27,4030,4026,00
27,400,401,46 %27,0028,6026,80
26,801,405,22 %25,4028,4025,20
25,400,602,36 %24,8028,2024,60
27,400,000 %27,4028,6025,60
26,803,4012,69 %23,4028,0023,40
24,601,004,07 %23,6025,0022,40
25,000,000 %25,0026,4024,00
28,202,408,51 %25,8029,0022,80
27,264,6016,87 %22,6630,7222,66
24,74−0,26−1,05 %25,0031,7823,22
36,62−30,16−82,36 %66,7874,9033,90
32,6013,8842,58 %18,7237,7418,08
17,50−2,10−12 %19,6019,6217,50
19,800,000 %19,8020,0018,60
20,460,160,78 %20,3021,4619,60
20,280,281,38 %20,0020,5018,64
20,26−2,40−11,85 %22,6622,6618,44
17,52−1,10−6,28 %18,6219,6016,96
18,82−0,06−0,32 %18,8820,5418,10
20,401,949,51 %18,4622,2417,50
18,620,623,33 %18,0018,7817,60
20,323,2215,85 %17,1020,5616,10
16,00−1,64−10,25 %17,6418,9616,00
17,540,603,42 %16,9417,9416,10
19,40−0,40−2,06 %19,8020,3818,92
19,80−0,40−2,02 %20,2020,3219,24
20,800,281,35 %20,5220,8020,02
21,300,100,47 %21,2021,3020,18
21,30−0,42−1,97 %21,7221,8019,92
21,720,421,93 %21,3024,5821,06
20,80−0,20−0,96 %21,0021,0819,16
21,301,667,79 %19,6421,7019,06
20,460,180,88 %20,2822,0019,60
21,88−2,44−11,15 %24,3226,4820,30
20,801,748,37 %19,0621,9617,88
19,041,286,72 %17,7619,4217,60
19,76−2,40−12,15 %22,1622,1819,76
25,14−1,72−6,84 %26,8626,8823,76
27,700,461,66 %27,2428,2826,68
26,40−4,84−18,33 %31,2431,6026,16
27,84−0,10−0,36 %27,9431,1027,08
27,40−2,52−9,2 %29,9230,7626,98
30,02−0,32−1,07 %30,3433,3030,00
32,440,401,23 %32,0433,9232,00
35,603,309,27 %32,3047,3231,86
37,001,002,7 %36,0037,0031,60
40,00−16,02−40,05 %56,0258,9838,40
45,10−32,66−72,42 %77,7683,0044,24
122,00−20,70−16,97 %142,70195,12105,02
105,5448,8646,3 %56,68129,4849,18
26,00−2,00−7,69 %28,0029,2625,02
27,82−1,38−4,96 %29,2029,2026,68
29,22−2,56−8,76 %31,7831,7828,58
31,782,668,37 %29,1232,3028,00
29,08−7,52−25,86 %36,6036,7628,88
36,002,747,61 %33,2636,5831,40
34,00−16,00−47,06 %50,0051,5032,20
54,02−573,98−1 062,53 %628,00630,0046,00
636,00−32,00−5,03 %668,00670,00630,00
662,0064,009,67 %598,00682,00598,00
596,00−18,00−3,02 %614,00630,00586,00
616,00−28,00−4,55 %644,00644,00600,00
648,008,001,23 %640,00672,00622,00
650,00−30,00−4,62 %680,00688,00626,00
684,00−16,00−2,34 %700,00744,00660,00
710,00120,0016,9 %590,00732,00590,00
576,00−28,00−4,86 %604,00616,00570,00
602,006,001 %596,00628,00586,00
602,00−8,00−1,33 %610,00630,00562,00
590,0056,009,49 %534,00606,00512,00
538,00−12,00−2,23 %550,00562,00526,00
536,00−52,00−9,7 %588,00588,00534,00
582,00−2,00−0,34 %584,00606,00574,00
556,00−16,00−2,88 %572,00588,00544,00
572,00−46,00−8,04 %618,00618,00570,00
600,00−68,00−11,33 %668,00674,00590,00
670,0018,002,69 %652,00670,00640,00
652,00−24,00−3,68 %676,00678,00636,00
680,00−32,00−4,71 %712,00712,00676,00
712,00−20,00−2,81 %732,00736,00674,00
732,000,000 %732,00750,00720,00
734,008,001,09 %726,00752,00722,00
730,002,000,27 %728,00758,00716,00
714,0020,002,8 %694,00732,00686,00
696,00−56,00−8,05 %752,00790,00688,00
744,00−16,00−2,15 %760,00798,00712,00
740,00−28,00−3,78 %768,00800,00740,00
754,00−90,00−11,94 %844,00850,00746,00
844,00−38,00−4,5 %882,00908,00840,00
880,0094,0010,68 %786,00896,00780,00
798,0022,002,76 %776,00814,00748,00
772,00−8,00−1,04 %780,00800,00760,00
780,00−14,00−1,79 %794,00806,00718,00
802,0066,008,23 %736,00860,00730,00
720,0014,001,94 %706,00742,00704,00
704,0028,003,98 %676,00740,00660,00
676,0044,006,51 %632,00686,00602,00
634,00−86,00−13,56 %720,00730,00584,00
730,0038,005,21 %692,00744,00656,00
690,00136,0019,71 %554,00716,00552,00
534,0030,005,62 %504,00566,00500,00
500,0070,0014 %430,00540,00430,00
428,0022,005,14 %406,00430,00390,00
408,0018,004,41 %390,00418,00384,00
386,000,000 %386,00390,00368,00
382,0028,007,33 %354,00390,00340,00
360,0018,005 %342,00376,00336,00
336,0010,002,98 %326,00350,00322,00
336,00−6,00−1,79 %342,00348,00326,00
342,00−12,00−3,51 %354,00366,00322,00
358,0042,0011,73 %316,00366,00288,00
320,000,000 %320,00332,00316,00
312,00−2,00−0,64 %314,00316,00304,00
318,00−4,00−1,26 %322,00324,00312,00
316,00−4,00−1,27 %320,00326,00310,00
320,008,002,5 %312,00324,00310,00
326,00−6,00−1,84 %332,00334,00314,00
330,002,000,61 %328,00336,00318,00
330,00−2,00−0,61 %332,00338,00326,00
336,00−6,00−1,79 %342,00346,00332,00
346,00−4,00−1,16 %350,00358,00338,00
358,00−4,00−1,12 %362,00374,00350,00
352,002,000,57 %350,00366,00350,00
356,00−6,00−1,69 %362,00368,00350,00
364,002,000,55 %362,00366,00352,00
364,00−14,00−3,85 %378,00390,00354,00
370,002,000,54 %368,00378,00358,00
372,00−18,00−4,84 %390,00390,00366,00
386,00−4,00−1,04 %390,00408,00380,00
396,006,001,52 %390,00400,00382,00
388,00−10,00−2,58 %398,00402,00382,00
392,0020,005,1 %372,00394,00364,00
374,00−46,00−12,3 %420,00430,00370,00
408,0030,007,35 %378,00418,00372,00
384,0034,008,85 %350,00390,00336,00
356,00−32,00−8,99 %388,00410,00328,00
390,0050,0012,82 %340,00392,00334,00
330,00−2,00−0,61 %332,00336,00326,00
328,004,001,22 %324,00332,00324,00
324,00−2,00−0,62 %326,00334,00322,00
326,006,001,84 %320,00328,00320,00
322,000,000 %322,00330,00318,00
322,00−4,00−1,24 %326,00334,00318,00
326,006,001,84 %320,00332,00320,00
324,004,001,23 %320,00328,00320,00
322,006,001,86 %316,00326,00316,00
324,008,002,47 %316,00328,00314,00
320,000,000 %320,00326,00316,00
322,00−10,00−3,11 %332,00332,00318,00
322,00−4,00−1,24 %326,00334,00322,00
324,002,000,62 %322,00330,00320,00
320,000,000 %320,00324,00316,00
320,004,001,25 %316,00324,00316,00
316,00−4,00−1,27 %320,00334,00314,00
322,000,000 %322,00332,00322,00
322,0010,003,11 %312,00330,00312,00
314,00−4,00−1,27 %318,00324,00314,00
322,002,000,62 %320,00324,00314,00
320,004,001,25 %316,00328,00314,00
322,008,002,48 %314,00324,00308,00
320,00−6,00−1,88 %326,00326,00308,00
320,0018,005,63 %302,00322,00294,00
308,00−12,00−3,9 %320,00320,00304,00
312,00−8,00−2,56 %320,00324,00312,00
320,002,000,63 %318,00322,00316,00
316,00−10,00−3,16 %326,00334,00316,00
326,006,001,84 %320,00340,00316,00
322,00−2,00−0,62 %324,00330,00320,00
326,006,001,84 %320,00332,00318,00
322,00−8,00−2,48 %330,00338,00320,00
334,00−2,00−0,6 %336,00340,00332,00
338,002,000,59 %336,00350,00326,00
336,00−12,00−3,57 %348,00354,00332,00
344,00−20,00−5,81 %364,00368,00344,00
366,0050,0013,66 %316,00386,00312,00
320,00−6,00−1,88 %326,00334,00308,00
330,00−4,00−1,21 %334,00338,00318,00
334,004,001,2 %330,00340,00310,00
332,00−2,00−0,6 %334,00340,00320,00
338,00−12,00−3,55 %350,00350,00330,00
326,00−6,00−1,84 %332,00334,00326,00
336,004,001,19 %332,00340,00326,00
338,006,001,78 %332,00342,00324,00
330,00−10,00−3,03 %340,00348,00328,00
336,00−34,00−10,12 %370,00374,00330,00
360,00−10,00−2,78 %370,00374,00350,00
370,000,000 %370,00374,00362,00
372,00−4,00−1,08 %376,00376,00350,00
372,0018,004,84 %354,00372,00354,00
354,00−36,00−10,17 %390,00390,00352,00
380,00−2,00−0,53 %382,00394,00366,00
378,0014,003,7 %364,00394,00354,00
366,0036,009,84 %330,00366,00330,00
336,00−10,00−2,98 %346,00356,00334,00
346,00−16,00−4,62 %362,00362,00342,00
356,00−12,00−3,37 %368,00378,00350,00
364,0010,002,75 %354,00410,00354,00
356,0014,003,93 %342,00368,00334,00
342,0022,006,43 %320,00346,00308,00
322,00−6,00−1,86 %328,00334,00318,00
326,004,001,23 %322,00340,00312,00
322,002,000,62 %320,00330,00302,00
320,0022,006,88 %298,00332,00296,00
304,00−24,00−7,89 %328,00334,00302,00
330,0018,005,45 %312,00336,00302,00
310,008,002,58 %302,00310,00286,00
300,00−18,00−6 %318,00318,00294,00
320,0032,0010 %288,00322,00284,00
290,0028,009,66 %262,00294,00260,00
264,004,001,52 %260,00266,00260,00
260,00−22,00−8,46 %282,00286,00260,00
272,004,001,47 %268,00280,00266,00
272,006,002,21 %266,00274,00258,00
276,00−12,00−4,35 %288,00288,00266,00
286,0046,0016,08 %240,00290,00238,00
240,00−14,00−5,83 %254,00254,00232,00
250,0010,004 %240,00256,00238,00
240,006,002,5 %234,00240,00234,00
234,00−4,00−1,71 %238,00238,00232,00
234,00−6,00−2,56 %240,00242,00230,00
238,0018,007,56 %220,00242,00220,00
218,002,000,92 %216,00218,00212,00
210,00−4,00−1,9 %214,00216,00208,00
212,000,000 %212,00214,00204,00
208,000,000 %208,00210,00202,00
208,00−2,00−0,96 %210,00213,44208,00
212,004,001,89 %208,00222,00200,06
204,00−22,00−10,78 %226,00226,00186,00
222,004,001,8 %218,00228,00208,00
218,0014,006,42 %204,00228,00200,00
206,002,000,97 %204,00208,00188,04
204,0023,6011,57 %180,40206,00180,40
189,8619,8610,46 %170,00190,00168,00
170,0013,507,94 %156,50175,00156,50
167,80−0,20−0,12 %168,00174,00144,06
168,28−23,72−14,1 %192,00192,00162,02
190,00−14,00−7,37 %204,00204,00185,58

Susijusios diskusijos

Sciatix

prieš 5 dienas

Lovely movement

What’s triggered this

Snaga

prieš 3 mėnesius

Slowly and steady

Good to see some recovery lets hope for a rocket for the 2027 year

Pleasing

prieš 3 mėnesius

New analyst target rating set of $82

New analyst target rating set of $82

Sciatix

prieš 3 mėnesius

Anyone got info

What’s the crack with this fkn stock.

Sciatix

prieš 4 mėnesius

Beyond a joke

The management need to get their act together quickly.

Ollie130406

prieš 5 mėnesius

Are these ever recovering

These shares are shite bought in at 8 dollars down about 80% can’t bring myself to sell will we see a recovery ever

Sciatix

prieš 5 mėnesius

This is an absolute dud

Can’t believe I broke my rule on buying shite.

Damo75

prieš 5 mėnesius

Absolute crap

These shares are absolute crap, been at a loss for ages, wish I never bought them.

Llinxtt

prieš 5 mėnesius

Pretty good entry’s…

Pretty good entry’s…

Sciatix

prieš 5 mėnesius

What the hell

This is doing my head in.

idk30008

prieš 5 mėnesius

What’s happening ?

I reckon news really soon , hopefully

Damo75

prieš 6 mėnesius

Poor

What’s a total !@#$ show these stocks are been at a total loss for ages

Uross03

prieš 6 mėnesius

Im in

In at 1.42 Wish me luck (if there’s any)!

Cl1f0

prieš 6 mėnesius

VOLUME IS UP⬆️⬆️⬆️

Little spike and looking at the volume there will be another soon. No merger yet but I keep saying we only need to stay above $1 for another week and then we have a high percentage of merger talks thats when we see a rocket. But thats wont be the half of it any of these private companies are looking to merge. And let me tell you they are looking for a shell. Then this is a game changer. It does have to happen to be a game changer but QNCX has the best fit out of all the shells. 1. Xaira Therapeutics Backing: Launched in April 2024 with $1 billion in committed funding from major firms like ARCH Venture Partners and Foresite Capital. Why it fits: It is one of the only private biotechs to actually hit the $1 billion funding mark in a single launch. They focus on AI-driven drug discovery, a high-value sector that often attracts significant investor interest. 2. Kailera Therapeutics Backing: Has raised approximately $1 billion in total private funding as of late 2025/early 2026, including a massive $600 million Series B. Industry Focus: Obesity (GLP-1) and related metabolic diseases. Status: While they recently launched an IPO roadshow, many companies in this sector keep a "dual-track" strategy, meaning they evaluate reverse mergers with shells like QNCX simultaneously with IPO plans. 3. Eikon Therapeutics Backing: Valued at approximately $3.2 billion with significant private backing from investors like T. Rowe Price and Canada Pension Plan Investment Board. Industry Focus: Advanced microscopy and drug discovery. Recent Activity: They recently completed an IPO in early 2026, but were long considered a primary candidate for a major public market entry.

idk30008

prieš 6 mėnesius

Can we pls see news today !!

Honestly what was the point of clearing debt and doing a 10-1 split, if this was gonna die and if we weren’t gonna stay above $1, hopefully there’s news today or tomorrow, or consider this dead

Analyst101

prieš 6 mėnesius

Somethings happening behind closed doors

Somethings happening behind closed doors

cianlewis

prieš 6 mėnesius

RS completed

the halt is over, let's push

Cl1f0

prieš 6 mėnesius

RS 1-for-10 if a merger is on the cards

Ive been doing a little digging and found some previous similar scenarios all available for you to look the Internet. Because Its blown my mind how $5.5m has been paid if they expect to go bankrupt. Therefore i think there is something in the pipeline. Everything is strictly private and no info to be given. So asking AI to find me similar scenarios 1. MDGL 2. IRON 3. TECX 4.LH 5. BKNG The first 3 have similar failed drug trail and then were merged after RS as a shell and not failed company, they are all above $30.72 and MDGL is $527. I believe we have potential to be sitting pretty here. Im not selling and if it stays above $1 then we look like were have a good start. Pretty sure it has to hold for an actual handshake but this could be one of them gems. Fingers crossed. And for all you holding im with you. NFA

Šiame puslapyje gali būti bendruomenės sukurto turinio, už kurį „Trading 212“ neatsako. Visada atlik savo tyrimą. „Trading 212“ teikia tik vykdymo paslaugą, bet neteikia investavimo konsultacijų ar portfelio valdymo paslaugų.

Investavimas be komisinių visiems

Pirk ir parduok IRulya Therapeutics Inc +0,25 $ (0,76 %) ir daugiau nei 13 000 pasaulinių vertybinių popierių ir ETF

Gali būti taikomi kiti mokesčiai. Žr. mūsų sąlygas ir mokesčius.

Peržiūrėk mūsų sąlygas ir mokesčius čia

phone

Įsigyk vertybinių popierių iškart

Pasirink mėgstamiausią įmonę

Pasirink, kiek investuoti

Gauk akcijų per kelias sekundes

Turto kaupimas – įprotis.
Automatizuokite jį naudodami Pies.

Investuok į paruoštus arba susikurk savo investicijų rinkinius, pasirinkdamas iš daugybės vertybinių popierių ir ETF

Sužinok daugiau

Sužinok daugiau

Žiūrėti vaizdo įrašą

Turėk net brangiausių akcijų, tokių kaip „Google“, „Amazon“ ir „Apple“

Žiūrėti vaizdo įrašą

Peržiūrėk visas prekybos priemones

Pagalba visą parą

29 sekundžių vidutinis atsako laikas

Pradėk kaupti turtą jau dabar

Prisijunk prie daugiau nei 5 mln. naudotojų

Atsisiųsti programėlę

Atidaryti sąskaitą

Atsisiųsk mobiliąją programėlę

qr-code

Visi pateikti statistiniai duomenys yra globalūs. Klientų skaičius atspindi finansuotas sąskaitas.

Puiku

Įvertinta 4,6/5, remiantis 106 426 atsiliepimais apie

Trustpilot

Įvertinta 4,6/5, remiantis 106 426 atsiliepimais apie

Trustpilot

Pakviestas

Excellent

Using Trading 212 has been a very productive and satisfying experience for me. Because the platform is user-friendly, dependable, and simple to navigate, investing is made to be a straightforward and convenient process. I am especially grateful for the user-friendly interface, the useful investment tools, and the capability to track the performance of my portfolio in real time.

Pakviestas

I have had a fantastic experience with…

have had a fantastic experience with Trading 212. The app is modern, intuitive and incredibly easy to use, making investing feel accessible and straightforward. I particularly appreciate the clear layout, real-time updates and the ability to manage my investments conveniently in one place. The overall experience is smooth, efficient and user-friendly. Whether you are new to investing or more experienced, Trading 212 is an excellent platform that I would happily recommend to others. A brilliant app that makes investing simple!

Pakviestas

Easy to use and fantastic features

Easy to use and fantastic features

Pakviestas

Easy to operate app for everyone!

Easy to operate app for everyone!

Pakviestas

Good platform for all my investments in…

Good platform for all my investments in one place. I have ISA and recently transferred my SIPP. I have a general investment account link to 121 debit card.

Pakviestas

Awesome service and app

Awesome service and app. Well done guys :)

Pakviestas

Everything is just so easy to use

Everything is just so easy to use. You can see at a glance how everything is doing.

Pakviestas

Just a great platform user friendly 0…

Just a great platform user friendly 0 commissions with the pie attachment whats not to like choosing 212 compared to other platforms is literally a no brainer

Pakviestas

Great app easy to move money in/out…

Great app easy to move money in and out. Good to see how much interest you are making.

Pakviestas

Easy to use and intuitive

Easy to use and great dashboard to see what’s going on. Moved my stocks and shares ISA from Barclays and not looked back.

Pakviestas

Easy to use app

Easy to use app, simple processes, good rate of return and regular updates on interest earned.

Pakviestas

Quick and easy

I found that it was quick and easy to open an account; transfer funds in and out, best of all, to sit back and watch the monies increase. I would recommend Trading 212

Pakviestas

App is easy to use

The savings product i have has a good rate of return and I get daily updates. App is really easy to use

Pakviestas

212 has been a good discovery 6 years ago

212 has been a good discovery. Excellent platform for investment, secure and user friendly. Very good interest rate and good ISA

Pakviestas

Love it

Love it. Simple for a complete beginner to navigate. Perfect!

Pakviestas

The best app around

The best app around, so easy to use and navigate… makes investing easy.

Pakviestas

Easy access to transfer money.

Easy access to transfer money. Daily updates regarding interest.

Pakviestas

Great platform

Great platform, easy to navigate and buy/sell. Good statements are available.

Pakviestas

Trading 212 is very transparent

Trading 212 is very transparent, open and clear with their activities. No outrageous deductions or charges. I recommend it for everyone interested in investment

Pakviestas

Good and efficient

Good and easy to use with lots of products and investment options

Pateikiami keli teigiami mūsų klientų atsiliepimai

Mūsų apdovanojimai

Dažniausiai užduodami klausimai

Kokia yra IRulya Therapeutics akcijos kaina?

Dabartinė IRulya Therapeutics kaina yra 33,08 $.

Koks yra IRulya Therapeutics52 savaičių maksimumas?

52 savaičių maksimumas IRulya Therapeutics yra 908 $.

Koks yra IRulya Therapeutics 52 savaičių žemiausias lygis?

52 savaičių žemiausias IRulya Therapeutics kursas yra 15,1 $.

Koks yra IRulya Therapeutics savaitės rezultatas?

Per pastarąją savaitę IRulya Therapeutics kaina pasikeitė 3,28 %.

Koks yra IRulya Therapeutics mėnesio našumas?

Per pastarąjį mėnesį IRulya Therapeutics kaina pasikeitė 5,52 %.

Koks yra IRulya Therapeutics 3 mėnesių rezultatas?

Per pastaruosius tris mėnesius IRulya Therapeutics kaina pasikeitė 78,43 %.

Koks yra IRulya Therapeutics 6 mėnesių rezultatas?

Per pastaruosius šešis mėnesius IRulya Therapeutics kaina pasikeitė 20,73 %.

Koks yra IRulya Therapeuticsmetinis našumas?

Per pastaruosius metus IRulya Therapeutics kaina pasikeitė −90,91 %.